VEGFA and neoplasm: Studies have shown that antiangiogenic drugs can promote tumor vascular normalization by antagonizing VEGF signaling, helping to relieve T-cell immunosuppression and promote T-cell accumulation in tumors; moreover, antiangiogenic drugs can also block VEGF-mediated suppression of dendritic cell functions, which can effectively positively regulate the immune function of the body [33, 34].